Cargando…

Therapeutic Potential of Targeting Prokineticin Receptors in Diseases

The prokineticins (PKs) were discovered approximately 20 years ago as small peptides inducing gut contractility. Today, they are established as angiogenic, anorectic, and proinflammatory cytokines, chemokines, hormones, and neuropeptides involved in variety of physiologic and pathophysiological path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vincenzi, Martina, Kremić, Amin, Jouve, Appoline, Lattanzi, Roberta, Miele, Rossella, Benharouga, Mohamed, Alfaidy, Nadia, Migrenne-Li, Stephanie, Kanthasamy, Anumantha G., Porcionatto, Marimelia, Ferrara, Napoleone, Tetko, Igor V., Désaubry, Laurent, Nebigil, Canan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595023/ https://www.ncbi.nlm.nih.gov/pubmed/37684054 http://dx.doi.org/10.1124/pharmrev.122.000801

Ejemplares similares

Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation
por: Lattanzi, Roberta, et al.
Publicado: (2021)

Effects of Prokineticins on Cerebral Cell Function and Blood–Brain Barrier Permeability
por: Younes, Hadi, et al.
Publicado: (2023)

Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases
por: Nebigil, Canan G.
Publicado: (2017)

Prokineticin-Receptor Network: Mechanisms of Regulation
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Identification and Characterization of a New Splicing Variant of Prokineticin 2
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection
por: Gasser, Adeline, et al.
Publicado: (2019)

The Emerging Role of the Prokineticins and Homeobox Genes in the Vascularization of the Placenta: Physiological and Pathological Aspects
por: Alfaidy, Nadia, et al.
Publicado: (2020)

Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1
por: Gasser, Adeline, et al.
Publicado: (2015)

Identification of Regions Involved in the Physical Interaction between Melanocortin Receptor Accessory Protein 2 and Prokineticin Receptor 2
por: Fullone, Maria Rosaria, et al.
Publicado: (2022)

Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy
por: Reynaud, Deborah, et al.
Publicado: (2021)

Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development
por: Arora, Himanshu, et al.
Publicado: (2016)

Prokineticin Receptor 1 as a Novel Suppressor of Preadipocyte Proliferation and Differentiation to Control Obesity
por: Szatkowski, Cécilia, et al.
Publicado: (2013)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Differential arousal regulation by prokineticin 2 signaling in the nocturnal mouse and the diurnal monkey
por: Zhou, Qun-Yong, et al.
Publicado: (2016)

Correction: Nguyen T.L., et al. Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells. J. Dev. Biol. 2013, 1, 20–31
por: Nguyen, Thu Lan, et al.
Publicado: (2020)

Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020)

Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
por: Gordon, Richard, et al.
Publicado: (2016)

Prokineticin Receptor‐1 Is a New Regulator of Endothelial Insulin Uptake and Capillary Formation to Control Insulin Sensitivity and Cardiovascular and Kidney Functions
por: Dormishian, Mojdeh, et al.
Publicado: (2013)

Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells
por: Qureshi, Rehana, et al.
Publicado: (2017)

Discovery of GPCR ligands for probing signal transduction pathways
por: Brogi, Simone, et al.
Publicado: (2014)

Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
por: Thuaud, Frédéric, et al.
Publicado: (2013)

Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies
por: Hsu, Po-Yen, et al.
Publicado: (2021)

Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses
por: Nebigil, Canan G., et al.
Publicado: (2020)

The flavagline FL3 interferes with the association of Annexin A2 with the eIF4F initiation complex and transiently stimulates the translation of annexin A2 mRNA
por: Grindheim, Ann Kari, et al.
Publicado: (2023)

The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
por: Lattanzi, Roberta, et al.
Publicado: (2021)

The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1
por: Franchi, Silvia, et al.
Publicado: (2008)

Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
por: Zuena, Anna Rita, et al.
Publicado: (2019)

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease
por: Panicker, Nikhil, et al.
Publicado: (2019)

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
por: Maftei, Daniela, et al.
Publicado: (2022)

Critical role for prokineticin 2 in CNS autoimmunity
por: Abou-Hamdan, Mhamad, et al.
Publicado: (2015)

Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2
por: Dodé, Catherine, et al.
Publicado: (2006)

Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation
por: Gordon, Richard, et al.
Publicado: (2012)

Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
por: Malovic, Emir, et al.
Publicado: (2021)

Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27
por: Bernard, Yohann, et al.
Publicado: (2011)

New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans
por: Mortreux, Marie, et al.
Publicado: (2019)

FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity
por: Qureshi, Rehana, et al.
Publicado: (2015)

Potential roles of the prokineticins in reproduction
por: Maldonado-Pérez, David, et al.
Publicado: (2007)

Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease
por: Kanthasamy, Anumantha G, et al.
Publicado: (2008)

Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration
por: Asaithambi, Arunkumar, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5vckr00541srk2r7n4qo40f6qt